Internal Medicine, Hematology & Oncology · San Francisco, CA
NPI
1922250323
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3838 California St, #707
San Francisco, CA, 94118
Phone (415) 668-0160
Groups this clinician bills Medicare through
Medicare paid, 2024
$328K
14,682 services
Medicare patients, 2024
545
Average age 75
Drug cost, 2024
$4.2M
1,211 prescriptions
Company payments, 2025
$202
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gauri D Kelekar was code Q5106 (injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units), 2,360 times for 11 patients. In total Gauri D Kelekar billed 14,682 services in 38 codes, and Medicare paid $328K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,360 | 11 | $5.56 | $13K |
| 85025 Blood Count | Office | 823 | 254 | $7.60 | $6,259 |
| 99214 Office E&M - Established | Office | 632 | 374 | $114.31 | $72K |
| 99215 Office E&M - Established | Office | 587 | 189 | $169.81 | $100K |
| 36415 Venipuncture Blood Collection | Office | 438 | 201 | $8.63 | $3,782 |
| 96372 Injection Administration | Office | 141 | 26 | $13.93 | $1,964 |
| 99205 Office E&M - New | Office | 106 | 106 | $203.33 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 101 | 46 | $105.15 | $11K |
| 99223 Hospital E&M - Initial | Facility | 68 | 63 | $154.22 | $10K |
| 99205 Office E&M - New | Facility | 22 | 22 | $162.28 | $3,570 |
By year: 2022 $434K for 14,828 services; 2023 $293K for 14,124 services; 2024 $328K for 14,682 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 823 | 254 | $7.60 | $6,259 |
| 36415 Venipuncture Blood Collection | 438 | 201 | $8.63 | $3,782 |
Medicare prescription drug claims, 2024
In 2024, the drug Gauri D Kelekar prescribed most often to Medicare patients was Eliquis (Apixaban), with 120 prescriptions and refills. In total Gauri D Kelekar wrote 1,211 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 120 | 225 | 35 | $124K |
| Prochlorperazine Maleate Generic | 77 | 77 | 52 | $1,032 |
| Ondansetron Hcl Generic | 62 | 69 | 41 | $2,907 |
| Hydroxyurea Generic | 55 | 148 | 16 | $1,999 |
| Pantoprazole Sodium Generic | 51 | 78 | 20 | $445 |
| Loperamide Loperamide Hcl | 41 | 42 | 14 | $837 |
| Trazodone Hcl Generic | 37 | 87 | Under 11 | $153 |
| Brukinsa Zanubrutinib | 36 | 36 | Under 11 | $474K |
| Prednisone Generic | 34 | 39 | 11 | $128 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 32 | 32 | Under 11 | $399 |
| Dexamethasone Generic | 30 | 46 | 15 | $1,041 |
| Xarelto Rivaroxaban | 26 | 68 | Under 11 | $35K |
| Creon Lipase/Protease/Amylase | 25 | 29 | Under 11 | $20K |
| Tagrisso Osimertinib Mesylate | 24 | 24 | Under 11 | $579K |
| Imatinib Mesylate Generic | 24 | 26 | Under 11 | $70K |
Brand drugs: - claims; generic drugs: 795 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gauri D Kelekar $202 ($202 in general payments such as food, travel and fees) from 7 companies. The largest payer was Array Biopharma Inc with $51.02.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.